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osting by E
cense.Abstract Square-wave voltammetry was used to explore the adsorption property of oﬂoxacine
complex with iron ion on the hanging mercury drop electrode (HMDE). By employing the adsorp-
tive stripping voltammetric approach, a sensitive electroanalytical method for the quantitative anal-
ysis of oﬂoxacine antibiotic was achieved. A well-developed voltammetric peak was obtained in pH
7.5 Britton–Robinson buffer (B–R buffer) at 1400 mV. The cyclic voltammetric studies indicated
that the reduction process was irreversible and primarily controlled by adsorption. An investiga-
tions of the variation of adsorptive voltammetric peak current with supporting electrolyte, pH,
accumulation time, accumulation potential, ion concentration, scan rate, pulse amplitude, SW fre-
quency, working electrode area and convection rate has resulted in the recognition of optimal exper-
imental conditions for oﬂoxacine analysis. The studied electroanalytical signal showed a linear
response for oﬂoxacine in the concentration range 5 · 107 to 1.7 · 106 mol l1 (r= 0.999). A
limit of detection of 1.1 · 108 mol l1 (3.98 ppb) with relative standard deviation of 1.21 RSD%
and mean recovery of 99.6% were obtained. Possible interferences by several substances usually
present in pharmaceutical formulation were also evaluated. The analytical quantiﬁcation of oﬂox-
acine in commercially available pharmaceutical formulation was performed and compared with
data from HPLC technique.
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lsevier1. Introduction
Square Wave Adsorptive Stripping Voltammetry (SW-AdSV)
has been well characterized as an extremely sensitive source
for electroanalytical measurements since its establishment half
a century ago. Such electrochemical approach with improved
sensitivity and selectivity have promoted the development of
numerous analytical applications of ultra-trace determina-
tions of a variety of organic or inorganic substances, alike.
236 A.F. Al-GhamdiSW-AdSV method involves a stripping step carried out by
using a square wave time-potential waveform imposed on the
working electrode. The principle advantages of SW-AdSV over
other AdSV techniques (namely differential pulse and linear
sweep) are its enhanced powers of detection, speed of analysis
and freedom from sensitivity of dissolved oxygen in the ana-
lysed samples (Wang, 1994; Osteryoung and O’Dea, 1986;
Economou and Filden, 1993). There have been many reviews
devoted to emphasize and illustrate the wide spectrum and
scope of AdSV applications and potentialities in the analysis
of metal ions (Zaitsev et al., 1999; Abu Zuhri and Voelter,
1998) organic analytes (Brainina et al., 2000) and pharmaceu-
tical drugs and biomedical compounds (Alghamdi, 2002; Vire
et al., 1998).
Oﬂoxacine belongs to a group of broad spectrum antibiotics
called the quinolones. It works by entering the bacterial cell and
inhibiting a chemical called DNA-gyrase which is involved in
the production of genetic material (DNA). This antibiotic drug
prevents the bacteria from reproducing and their growth is
stopped. Oﬂoxacine is effective against several types of bacteria
that tend to be resistant to other commonly used antibiotics. It
is used to treat a wide range of infections, including infections of
the chest, urinary tract, pneumonia, bronchitis, venereal disease
(VD), and prostate, skin. It is also used as a single dose treat-
ment for gonorrhea. Oﬂoxacine is the racemic mixture of a
chiral compound. Its chemical IUPAC name (+/)-9-ﬂuoro-
2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-
pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid (Hayakava
et al., 1983; Truste Cerner Multum Inc. Version, 2006; Bethes-
da, 2006). The structural formula of this pharmaceutical
compound is exhibited in Scheme 1. This antibiotic drug has
been analysed in pharmaceutical formulations and biological
samples by various analytical methods such as spectrophotom-
etry (Hopkata and Kowalczuk, 2000; Garcia et al., 2005; Lisi-
ane and Schapoval, 2002; Kapetanovic et al., 1996; Patel
et al., 2007), high performance liquid chromatography (HPLC)
Lisiane and Schapoval, 2002; Kraas and Hirrle, 1986; Arai and
Hiroko, 1989; Espinosa-Mansilla et al., 2005; Tadashi et al.,
1991 and electrochemical method such as polarography linear
sweep voltammetry and cyclic voltammetry (Rizk et al., 1998;
Gerong and Jinghao, 1995; Nan and Xiaoli, 2007; Azcurra
et al., 2001; Chun-Hai et al., 2007). However, no literature data
was found on the square wave voltammetry in general or the
adsorptive stripping determination of this drug–Fe3+ in partic-
ular. Consequently, the development of SW-AdSV method for
the analysis oﬂoxacine after complex formation with Fe(III)
ion, and its application to determination in pharmaceutical for-
mulation, is described.H3C
N
N F
O
N
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O
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Scheme 1 Chemical structure of oﬂoxacine drug.2. Experimental
2.1. Apparatus
All adsorptive stripping measurements were carried out with
797 VA computrace (Metrohm, Switzerland) in connection
with Dell computer and controlled by (VA computrace 2.0)
control software. Stripping voltammograms were obtained
via a hp deskjet 5150 printer. A conventional three electrode
system was used in the hanging mercury drop electrode
(HMDE) mode. Chromatographic determination of this anti-
biotic drug was obtained by HPLC instrumental model LC-
20AT Shimadzu in connection with Dell computer. HPLC
chromatograms were printed via a hp LaserJet 1020 printer.
pH values were measured with Metrohm 632 pH meter (Swiss
made). Biohit adjustable micropipette (AU), and Brand adjust-
able micropipette (Germany), were used to measure microliter
volumes of the standard solutions.2.2. Reagents
All chemicals used were of analytical reagent grade and were
used without further puriﬁcation. Oﬂoxacine drug stock solu-
tion of 1 · 102 mol l1 was prepared by dissolving the appro-
priate amount of oﬂoxacine in ethanol in 25 ml volumetric
ﬂask and this stock solution was stored in the dark. Similarly,
Fe(III) stock solution of 1 · 103 mol l1 was prepared by dis-
solving the appropriate amount of ironnitrate salt in dilute nitric
acid in 50 ml volumetric ﬂask. Britton–Robinson supporting
buffer (pH 2, 0.04 M in each constituent) was prepared by dis-
solving 2.47 g of boric acid (winlab, UK) in 500 ml distilled
water containing 2.3 ml of glacial acetic acid (BDH, UK) and
then adding 2.7 ml of ortho-phosphoric acid (Riedal-deHaen,
Germany) and diluting to 1 l with distilled water. In addition,
phosphate supporting buffer [0.1 M NaH2PO4 (winlab, UK)
and 0.1 MH3PO4] was prepared by dissolving 12 g of NaH2PO4
and 6.78 g ofH3PO4 in 1000 ml distilled water. Acetate support-
ing buffer (0.02 M in each constituent) was prepared by dissolv-
ing 1.68 g of sodium acetate (winlab, UK) in 500 ml distilled
water containing 1.12 ml of acetic acid and diluting to 1 l with
distilled water. Finally, carbonate supporting buffer (0.1 M in
each constituent) was prepared by dissolving 10.6 g of sodium
carbonate (BDH, UK) and 8.4 g of sodium hydrogen carbonate
(winlab, UK) in 1 l distilled water.2.3. Procedure
The general procedure adopted for obtaining square wave
adsorptive stripping voltammograms was as follows: A 10 ml
aliquot of B–R supporting buffer (unless otherwise stated) at
desired pH was pipetted in a clean and dry voltammetric cell
and the required standard solutions of oﬂoxacine complex
were added. The test solutions were purged with nitrogen for
5 min initially, while the solution was stirred. The accumula-
tion potential of 0.0 V vs. Ag/AgCl was applied to a new mer-
cury drop while the solution was stirred for 100 s. Following
the preconcentration period, the stripping was stopped and
after 20 s had elapsed, cathodic scans were carried out over
the range 0.0 to 1.7 V. All measurements were made at room
temperature.
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3.1. The electroanalytical properties of oﬂoxacine complex
Preliminary stripping voltammetric experiments show that oﬂ-
oxacine pharmaceutical molecule (5 · 107 mol l1) gave a
well-deﬁned (line B) cathodic peak at  1400 mV (vs. Ag/AgCl
reference electrode) in pH 7 Britton–Robinson buffer as can be
seen from Fig. 1. Then, the addition of 5 · 106 mol l1 Fe(III)
to the previous oﬂoxacine test solution increased a well-deﬁned
(line C) cathodic peak. Also, the addition of 1 · 106 mol l1
oﬂoxacine drug to the solution increased the cathodic current
(line D), all additions were made at potential 1400 mV. In
fact, the iron(III) ions exhibited a good afﬁnity towards oﬂox-
acine molecules forming a very stable oﬂoxacine–Fe(III) com-Figure 1 Electrochemical behavior of oﬂoxacine complex with
iron(III) ions: (A = buffer, B = buffer + 5 · 107 M oﬂoxacine,
C = A+ B+ 5 · 106 M Fe+3, D = A+ B+ C+ 1 · 106 M
oﬂoxacine).
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Scheme 2 Suggested mechanism of the studied electrochemplex which is strongly adsorbed onto the HMDE surface.
This obtained well-developed stripping voltammetric peak
was found to response sharply to the addition of either oﬂoxa-
cine or Fe(III) concentrations (lines B, C and D), which prob-
ably reﬂect the formation and adsorption of the suggested
complex. The observed AdSV peak is most probably due to
the cathodic reduction of Fe(III) in the adsorbed complex with
oﬂoxacine and the electrochemical mechanism of this reduction
process for oﬂoxacine–Fe(III) complex is illustrated in Scheme
2.
Clearly, this proposed electrochemical reduction mechanism
suggested an irreversible reductive process for iron ion in the ad-
sorbed complex, an assumption which was conﬁrmed by cyclic
voltammetric measurement of 1 · 104 mol l1 oﬂoxacine drug
and 1 · 103 mol l1 Fe(III) in pH 7.5 B–R buffer at 50 mV s1
scan rate. As can be noticed fromFig. 2, which exhibits the cyclicF
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ical reduction process for oﬂoxacine–iron(III) complex.
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Figure 2 Cyclic voltammogram for 1 · 104 mol l1 oﬂoxacine
with Fe3+ (1 · 103 mol l1) in pH 7.5 B–R buffer at 50 mV s1
scan rate. Accumulation time 60 s at Eacc: 0.0 V.
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Figure 4 Effect of accumulation time on the stripping voltam-
metric peak current of 5 · 107 mol l1 oﬂoxacine drug and
5 · 106 mol l1 Fe(III) in pH 7.5 B–R buffer. Accumulation
potential: 0.0 V.
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dic peak at the reverse scan conﬁrmed the irreversible nature of
the evaluated reduction process. Furthermore, when repetitive
cyclic voltammetric measurements for oﬂoxacine complex with
Fe(III) were carried out, a well-developed AdSV peak was ob-
served at all cathodic scans, however, succeeding cathodic scans
exhibit a gradual increase in the voltammetric peak intensity,
that seemed to indicate the adsorptive characteristic of this com-
plex at the surface of the employed working electrode. Anyhow,
the interfacial accumulation of this drug–metal ion complex
onto the HMDE surface can be used as an effective accumula-
tion step in order to enhance the electroanalytical determination
of oﬂoxacine molecules.
3.2. Optimization of experimental parameters
3.2.1. Effect of supporting buffer constituents and pH
Since the adsorptive phenomena of oﬂoxacine complex on the
HMDEwas utilized as a suitable collection step prior to its elec-
trochemical determination, it was rational to characterize vari-
ous variables and experimental conditions that affecting the
engaged adsorption process. In fact, the sensitivity of the
adsorptive stripping procedure for a particular analyte is usually
signiﬁcantly inﬂuenced by the composition of the supporting
buffer and pH value. Consequently, several supporting buffers
such as Britton–Robinson, phosphate, acetate and carbonate
buffers at different pH values were evaluated after 60 s accumu-
lation time at 0.0 V accumulation potential. Among these sup-
porting electrolytes the best electroanalytical signal in terms of
SW-AdSV peak current intensity and shape was obtained with
B–R buffer, which was selected as optimal for further works.
Generally, the AdSV signal was mainly pH dependent since
the monitored voltammetric signal was only observed at low
alkaline media. When the stripping voltammetric peak current
was measured as a function of pH over the range 5–9, the peak
current increased gradually at ﬁrst and enhanced sharply be-
yond pH 7 then it reached its maximum value at pH 7.5, which
was adopted as optimum pH value for subsequent investiga-
tions. The inﬂuence of pH factor on the SW-AdSV signal is
illustrated in Fig. 3. In addition, it was observed that the vol-
tammetric peak potential of this complex did not shifted when
pH was varied over the studied pH rang, which indicates that
Ep was pH independent as expected for an electrochemical
reaction in which hydrogen ions did not consumed.0
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Figure 3 Effect of pH on SW-AdSV peak current of
5 · 107 mol l1 oﬂoxacine drug and 5 · 106 mol l1 Fe(III) in
B–R buffer after an accumulation period of 60 s at Eacc = 0.0 V.3.2.2. Effect of accumulation factors
The interfacial accumulation of oﬂoxacine complex onto the
HMDE surface depends on some operational factors, which
worth additional investigations in order to ensure high sensi-
tive determinations of this drug via its Fe(III) complex. There-
fore, the effect of accumulation time on the efﬁciency of the
collection of 5 · 107 mol l1 oﬂoxacine drug in the presence
of 5 · 106 mol l1 iron(III) ions onto the working electrode
was evaluated by rising the accumulation time over the range
0–150 s. The resulting peak current-accumulation time (ip–
Tacc) proﬁle is exhibited in Fig. 4 and as can be seen from this
plot, a steadily enhancement in the peak current was observed
over the range 0–30 s and thereafter the peak intensity nearly
decreased probably due to the saturation of the HMDE.
Hence, 30 s accumulation time was selected for all future
experiments. Furthermore, variation of the accumulation po-
tential over the range from +0.4 to 1.2 V (see Fig. 5) at
30 s accumulation time, revealed that a preconcentration po-
tential of 1.0 V was the ideal choice for optimal sensitivity.
3.2.3. Effect of metal ion concentration
The dependence of the WS-AdSV voltammetric current of
5 · 107 mol l1 oﬂoxacine in a B–R buffer of pH 7.5 on the
concentration of iron(III) ions was also investigated. As shown
inFig. 6 the monitored voltammetric signal was approximately0
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Figure 5 Effect of accumulation potential on the stripping
voltammetric peak current of 5 · 107 mol l1 oﬂoxacine drug and
5 · 106 mol l1 Fe(III) in pH 7.5 B–R buffer. Accumulation time:
30 s.
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Figure 6 Effect of iron(III) ion concentration on the stripping
voltammetric peak current of 5 · 107 mol l1 oﬂoxacine drug in
pH 7.5 B–R buffer. Accumulation potential: 1.0 V and accumu-
lation time: 30 s.
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Figure 7 Effect of scan rate on AdSV peak current of
5 · 107 mol l1 oﬂoxacine drug and 5 · 106 mol l1 Fe(III) in
pH 7.5 B–R buffer. Accumulation time: 30 s and accumulation
potential: 1.0 V.
0
100
200
300
400
500
600
700
800
900
0 20 40 60 80 100 120
pulse amplitude (mV)
i (
-n
A
)
Figure 8 Effect of pulse amplitude on the stripping voltammetric
peak current of 5 · 107 mol l1 oﬂoxacine drug and 5 · 106
mol l1 Fe(III) in pH 7.5 B–R buffer. Accumulation time: 30 s,
accumulation potential: 1.0 V and scan rate: 700 mV s1.
0
100
200
300
400
500
600
0 50 100 150
frequency (Hz)
i (
-n
A
)
Figure 9 Effect of frequency on the stripping voltammetric peak
current of 5 · 107 mol l1 oﬂoxacine drug and 5 · 106 mol l1
Fe(III) in pH 7.5 B–R buffer. Accumulation time: 30 s, accumu-
lation potential: 1.0 V, scan rate: 700 mV s1 and pulse ampli-
tude 90 mV.
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Fe(III). For getting up good shape of cathodic peak, the metal
ion concentration of choice will be 5 · 106 mol l1 oﬂoxacine
–Fe3+.
3.2.4. Effect of potential sweep parameters
The observed stripping voltammetric signal can be further max-
imized by adjusting the way the applied potential was scanned.
The relationship between the measured peak intensity and scan
rate was found to be directly proportional over 100–700 mV s1
scan arte (from studied range 100–1000 mV s1). However,
when scan rates faster than 700 mV s1 were employed, the
peak current decreased slightly. The inﬂuence of scan rate on
the observed voltammetric signal is illustrated in Fig. 7, which
indicates that scan rate value of 700 mV s1 would be adequate
optimum for succeeding investigations.
In addition, the impact of varying the excitation wave pulse
amplitude on the voltammetric current intensity was also eval-
uated. The effect of this operating variable was studied over
the range 10–100 mV (see Fig. 8) and it was concluded that
in order to assure maximum peak current, 90 mV pulse
amplitude is the ideal choice for this operational parameter.
Moreover, varying the value of square wave frequency also
plays an important role for the measured signal of SW-AdSVapproach. Varying this parameter over the range 10–140 Hz
resulted in a substantial enhancement of the voltammetric
peak current particularly at range 10–120 Hz as can be seen
fromFig. 9, then the peak of current become constant. Accord-
ingly, for future work 120 Hz SW frequency value was
adopted.
3.2.5. Effect of other instrumental variables
The inﬂuence of other operating parameters such as the size of
the adsorption area (HMDE) and convection rate on the efﬁ-
ciency of the adsorption accumulation of oﬂoxacine complex
was additionally checked. As expected, a linear enhancement
for the electrochemical peak intensity was observed when the
surface area of HMDE was increased over the range
0.15–0.6 mm2 drop size area. Besides, the SW-AdSV peak cur-
rent can be maximized further by increasing the stirring rate of
the rotating rod over the range 0–3000 rpm. Hence, for opti-
mal sensitivity, 0.6 mm2 drop size and 3000 rpm stirring speed
were selected.
In conclusion, for electroanalytical purposes, the optimized
experimental conditions for SW-AdSV measurements of oﬂox-
acine drug–Fe(III) were accumulating his complex for 30 s at
1.0 V preconcentration potential with stirring rate of
240 A.F. Al-Ghamdi3000 rpm. These voltammetric measurements were carried
out in Britton–Robinson buffer at pH 7.5 in the presence of
5 · 106 mol l1 Fe(III). The applied potential was scanned
at 700 mV s1 with 120 Hz SW frequency rate and 90 mV
pulse amplitude.
3.3. Analytical performance
3.3.1. Calibration graph and detection limit
Once the optimal chemical conditions and instrumental
parameters for the SW-AdSV determination of oﬂoxacine were
established, several analytical characteristics of the proposed
were evaluated. Under the optimized conditions, a linear cor-
relation between SW-AdSV peak intensity and the drug con-
centration was obtained over the range 5 · 107 to 1.7 ·
106 mol l1, (see Fig. 10). The calibration equation was calcu-
lated by least-squares method and it has the form:
IpðnAÞ ¼ 3:2 108C ðmol l1Þ þ 1250 r ¼ 0:999; n ¼ 5:
where Ip is the stripping voltammetric peak current in nanoam-
peres, C is oﬂoxacine concentration and r is the correlation
coefﬁcient.
The effective preconcentration step during the adsorption
process of the analyzed drug allow a very low detectability.
The detection limit estimated based on the signal-to-noise ratio
(S/N = 3) was 1.1 · 108 mol l1 (3.98 ppb). This obtained
sensitivity was signiﬁcantly preferable than those reported
for other analytical techniques currently used for determina-
tion of oﬂoxacine drug such as chromatography method
(HPLC) with 14.5 ppb (Espinosa-Mansilla et al., 2005) and
20 ppb (Tadashi et al., 1991) detection limits and polarography
method with 108.4 ppb (Rizk et al., 1998) and 1445.5 ppb
(Gerong and Jinghao, 1995).
3.3.2. Precision, accuracy and stability
The reproducibility of the developed procedure was evaluated
from ten repeated measurements of 5 · 107 mol l1 oﬂoxacine
drug in the presence of 5 · 106 mol l1 Fe(III) ion. The preci-
sion of the method in terms of the relative standard deviation
(RSD%) was 1.21%. The accuracy of the electrochemical
method was checked by calculating the recovery of known
amount (2 · 107 mol l1 oﬂoxacine drug spiked in buffer
solution and analysed by the optimized procedure. The resultsFigure 10 AdSV voltammogram for oﬂoxacine in B–R buffer
pH 7.5, Tacc = 30 s, Eacc = 1.0 V, scan rate = 700 mV s1 and
metal conc. = 5 · 106 M. A = buffer signal. Drug concentra-
tions: (B = 5 · 107 M, C = 8 · 107 M, D = 1.1 · 106 M,
E = 1.4 · 106 M, F= 1.7 · 106 M).of ﬁve measurements obtained by the standard addition meth-
od have a recovery mean of 99.6% with standard deviation of
±0.55%. When the SW-AdSV signal of 5 · 107 mol l1 oﬂ-
oxacine drug solution in the presence of 5 · 106 mol l1
Fe3+ was monitored every 10 min, it was found to nearly sta-
ble for a period of 1.5 h at least.
3.3.3. Interferences
The competitive co-adsorption interference was evaluated in
the presence of various substance usually occur in the pharma-
ceutical formulation as tablet ingredients or additives. For
these investigations, the interfering species (lactose, sucrose,
cellulose, starch and magnesium satereate) were added at dif-
ferent concentrations (twice, 5-fold and 50-fold) higher than
the concentration of oﬂoxacine (5 · 107 mol l1 oﬂoxacine).
The additions of magnesium satereate, cellulose and starch
at high concentration level, caused the AdSV peak current to
decrease by about 8%, 17% and 11% respectively. In contrast,
the additions of sucrose and lactose at the drug solution no sig-
niﬁcant effect on the SW-AdSV response of oﬂoxacine.
This inhibition response is possibly due to the competitive
co-adsorption of these interfering substance (particularly at
higher concentration levels) on the adsorption sites of HMDE.
3.4. Analytical applications
The reliability of the proposed AdSV method for the determi-
nation of oﬂoxacine was investigated by assaying this drug in
some real samples. Following the developed electroanalytical
procedure described above, oﬂoxacine–Fe(III) was analysed
in pharmaceutical formulation. The oﬂoxacine content of com-
mercially available tablets (oﬂacin/200 mg oﬂoxacine, manu-
factured by Ram Pharmaceutical, Jordon) was determination
directly by the SW-AdSV method after the required dissolving
and ﬁltration steps. Five aliquots of the dissolved sample were
diluted to the required concentration level and measured via
the standard additions approach. For these studies, results ob-
tained gave a recovery mean 103.5% with standard deviation
of ±1.3%. As can be seen from Table 1, these results achieved
by the optimized AdSV procedure were in good agreement
with those obtained by HPLC technique for the analysis of
the same pharmaceutical tablets (oﬂacin-200 mg). Based on
the statistical evaluation (F-test approach) for these results,
there is no signiﬁcant difference between the results obtained
by the developed AdSV procedure and that obtained by the
reference method. When comparing the variances of the devel-
oped AdSV procedure and the chromatographic reference
method (HPLC), the calculated F value is 6.76. Whereas the
calculated F-test value (6.76) was less than the critical value
(9.28) at the 95% conﬁdence level. There is no statistical evi-
dence that the variance of the proposed method differ signiﬁ-
cantly from the variance of the reference method.
In addition, the applicability of the AdSV procedure for the
analysis of oﬂoxacine–Fe(III) in biological samples was also
evaluated by estimating its recovery from spiked human urine
and serum samples. A simple and fast pretreatment (clean-up)
procedure, which is in fact a slight modiﬁcation of the sample
preparation method develop for the determination of some
antagonist drugs (Stubauer and Obendorf, 1996) was used.
By adding a small amount of 5% ZnSO4Æ7H2O solution,
NaOH and methanol to the urine or serum samples and
Table 1 Comparative determination of oﬂoxacine–Fe(III) in commercial drug by the proposed SW-AdSV method and the reference
chromatographic method.
AdSV method Reference method (HPLC)
Found (mg) % Recovery Found (mg) % Recovery
Labeled content Oﬂacin Tablets (200 mg oﬂoxacine)
210 102 210 104
208 103 210 105
206 105 210 105
204 104 208 105
Mean 103.5 Mean 104.75
Standard deviation ±1.3 Standard deviation ±0.5
Table 2 Analytical result for oﬂoxacine–Fe(III) recovery
from biological ﬂuids.
% drug recovery
Spiked urine Spiked serum
Added oﬂoxacine 1.0 · 107 mol l1
103 105
104 105
104 106
Mean 103.7 105.33
Standard deviation ±0.6 ±0.6
A study of adsorptive stripping voltammetric behavior of oﬂoxacine antibiotic 241centrifuging the mixture, most of the interfering substances
(mainly proteins) were simply removed and eliminated by
precipitation. As can be extracted from Table 2, this AdSV
method (after appropriate dilution) allowed the determination
of oﬂoxacine–Fe(III) in spiked urine and serum samples
with mean recoveries 103.7%± 0.6 and 105.33%± 0.6,
respectively (note: conc. of Fe(III) equal 5 · 106 M in all
measurements).Acknowledgement
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